Network Meta-Analysis of Randomized Controlled Trials: Efficacy and Safety of UDCA-Based Therapies in Primary Biliary Cirrhosis

Major ursodeoxycholic acid (UDCA)-based therapies for primary biliary cirrhosis (PBC) include UDCA only, or combined with either methotrexate (MTX), corticosteroids (COT), colchicine (COC), or bezafibrate (BEF). As the optimum treatment regimen is unclear and warrants exploration, we aimed to compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Gui-Qi, Shi, Ke-Qing, Huang, Sha, Huang, Gui-Qian, Lin, Yi-Qian, Zhou, Zhi-Rui, Braddock, Martin, Chen, Yong-Ping, Zheng, Ming-Hua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2015
Materias:
4500
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602497/
https://www.ncbi.nlm.nih.gov/pubmed/25789951
http://dx.doi.org/10.1097/MD.0000000000000609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4602497/
https://www.ncbi.nlm.nih.gov/pubmed/25789951
http://dx.doi.org/10.1097/MD.0000000000000609

Ejemplares similares